AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More

AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
Researchers at Oregon Health & Science University (OHSU) have unveiled a groundbreaking discovery: a previously unrecognized internal system within cells…
Read More
In a landmark achievement for regenerative medicine and oncology, researchers from the University of Basel and University Hospital Basel have…
Read More
A groundbreaking study has identified a novel mechanism by which a single small molecule can leverage two distinct cellular pathways…
Read More
The global oncology community converged at the American Association for Cancer Research (AACR) 2026 Annual Meeting in San Diego, a…
Read More
A collaborative international study led by researchers at Ludwig Cancer Research has identified a breakthrough therapeutic strategy for acute myelogenous…
Read More
In a significant advancement for the field of oncology and molecular biology, investigators at the Johns Hopkins Kimmel Cancer Center…
Read More
Researchers from the University of Pennsylvania’s School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…
Read More
The effectiveness of groundbreaking therapeutic agents is intrinsically linked to their successful and precise delivery within the human body. Without…
Read More